Australia's most trusted
source of pharma news
Saturday, 14 February 2026
Posted 21 September 2016
GSK has announced that Emma Walmsley, currently chief executive officer of its Consumer Healthcare division, has been appointed GSK CEO Designate and will succeed Andrew Witty as GSK CEO when he retires on 31 March next year.
Ms Walmsley will join the GSK Board of Directors from January next year.

Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.
Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.